Drug recall · November 6, 2024
Chlorpheniramine Maleate 4 mg tablets recall
Why: Superpotent Drug: Stability failure for assay at 6 months test time-point.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Chlorpheniramine Maleate 4 mg tablets, 24-count bottle, Manufactured For: Athlete's Needs, Novi, MI 48377, NDC 53185-277-24
- Lots / codes
Lot # 24A27724, Exp 01/31/2027
- Quantity
- 4,901 cases/24 count each case
- Company
- BLI International, Inc., Deer Park, NY
- Distribution
- Product was shipped to two private label customers ( OH & MO) as a final packaged product.
- Initiated
- October 21, 2024 · Voluntary: Firm initiated
- Classified
- October 30, 2024
- Reported
- November 6, 2024
- Ended
- December 5, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Chlorpheniramine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.